Go Pro
Dan Brennan

Dan Brennan Analyst Performance

Senior Equity Research Analyst - Managing Director at TD Cowen

Dan Brennan is a stock analyst at TD Cowen focused in the healthcare sector, covering 25 publicly traded companies. Over the past year, Dan Brennan has issued 57 stock ratings, including buy and hold recommendations. While full access to Dan Brennan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Brennan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
64 Last 4 Years
Buy Recommendations
68.25% 43 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy68.3%43 ratings
Hold31.7%20 ratings
Sell0.0%0 ratings

Out of 63 total stock ratings issued by Dan Brennan at TD Cowen, the majority (68.3%) have been Buy recommendations, followed by 31.7% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
72.0% of companies on NASDAQ
18 companies
NYSE
28.0% of companies on NYSE
7 companies

Dan Brennan, an analyst at TD Cowen, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
24 companies
96.0%
Miscellaneous
1 company
4.0%

Dan Brennan of TD Cowen specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
14 companies
56.0%
BIOTECHNOLOGY
5 companies
20.0%
HEALTHCARE PROVIDERS & SERVICES
5 companies
20.0%
Miscellaneous
1 company
4.0%

About Dan Brennan

At TD Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science & Diagnostics Tools’ industry. This includes identifying key investment debates, building financial models, generating research reports, including ‘Ahead of the Curve’ deep dive analysis, making stock recommendations and engaging with clients and TD Cowen representatives. Daniel Brennan is a senior analyst covering Life Science & Diagnostic Tools. Prior to joining TD Cowen, Dan was a Managing Director and senior Life Science & Diagnostic Tools analyst at UBS. Prior to UBS, he was a senior health care analyst at Columbus Circle Investors. Dan also spent 19 years at Morgan Stanley, where he served, amongst other roles, as the health care sector equity sales specialist and later as the senior Life Science & Diagnostic Tools analyst. Mr. Brennan holds a BA in economics from Georgetown University, and an MBA from Harvard University. He is also a CFA® charterholder.
Follow on LinkedIn

Dan Brennan's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Freenome stock logo
FRNM
Freenome
8/18/2026Initiated Coverage$13.00$17.00Buy
Freenome stock logo
FRNM
Freenome
8/18/2026Initiated Coverage$13.63$17.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
8/11/2026Lower Price Target$2.49$3.00Hold
Natera, Inc. stock logo
NTRA
Natera
8/7/2026Boost Price Target$313.61$340.00Buy
Exagen Inc. stock logo
XGN
Exagen
8/5/2026Boost Price Target$6.74$10.00Buy
Waters Corporation stock logo
WAT
Waters
8/5/2026Upgrade$395.15$475.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
7/31/2026Boost Price Target$168.96$210.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
7/31/2026Boost Price Target$199.68$210.00Hold
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
7/30/2026Boost Price Target$22.88$28.00Buy
Danaher Corporation stock logo
DHR
Danaher
7/22/2026Lower Price Target$175.12$236.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
7/15/2026Reiterated Rating$58.08Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
7/15/2026Reiterated Rating$14.20Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
7/15/2026Reiterated Rating$72.93Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
7/15/2026Reiterated Rating$21.85Buy
Waters Corporation stock logo
WAT
Waters
7/15/2026Reiterated Rating$377.14Hold
Qiagen N.V. stock logo
QGEN
Qiagen
7/15/2026Reiterated Rating$41.95Hold
Revvity Inc. stock logo
RVTY
Revvity
7/15/2026Reiterated Rating$111.45Buy
ALMR
Alamar Biosciences
7/15/2026Reiterated Rating$27.23Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
5/28/2026Boost Price Target$135.58$155.00Buy
MDxHealth SA stock logo
MDXH
MDxHealth
5/14/2026Reiterated Rating$0.98$1.50Buy
ALMR
Alamar Biosciences
5/12/2026Initiated Coverage$23.88$30.00Buy
ALMR
Alamar Biosciences
5/12/2026Initiated Coverage$22.97$30.00Buy
Qiagen N.V. stock logo
QGEN
Qiagen
5/7/2026Reiterated Rating$33.72$40.00Hold
Quanterix Corporation stock logo
QTRX
Quanterix
5/7/2026Lower Price Target$2.72$4.00Hold
Waters Corporation stock logo
WAT
Waters
5/6/2026Boost Price Target$352.53$385.00Hold
GRAIL, Inc. stock logo
GRAL
GRAIL
5/6/2026Boost Price Target$55.73$69.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
5/6/2026Boost Price Target$13.44$21.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
5/6/2026Boost Price Target$54.07$68.00Buy
Revvity Inc. stock logo
RVTY
Revvity
5/6/2026Boost Price Target$99.54$120.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
4/29/2026Boost Price Target$8.35$14.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
3/16/2026Reiterated Rating$8.22Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2/26/2026Lower Price Target$115.34$157.00Buy
Exagen Inc. stock logo
XGN
Exagen
2/24/2026Lower Price Target$3.82$10.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$106.35$135.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2026Boost Price Target$19.27$19.00Hold
Bruker Corporation stock logo
BRKR
Bruker
2/13/2026Lower Price Target$37.12$43.00Hold
Avantor, Inc. stock logo
AVTR
Avantor
2/12/2026Reiterated Rating$9.66Hold
Revvity Inc. stock logo
RVTY
Revvity
2/3/2026Reiterated Rating$105.76Hold
Revvity Inc. stock logo
RVTY
Revvity
2/3/2026Boost Price Target$108.03$124.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/30/2026Lower Price Target$576.73$683.00Buy
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/7/2026Boost Price Target$618.81$696.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
1/7/2026Boost Price Target$149.46$140.00Hold
Danaher Corporation stock logo
DHR
Danaher
1/7/2026Boost Price Target$233.76$270.00Buy
Bruker Corporation stock logo
BRKR
Bruker
1/7/2026Boost Price Target$52.38$53.00Hold
10x Genomics stock logo
TXG
10x Genomics
1/7/2026Boost Price Target$19.71$18.00Hold
Avantor, Inc. stock logo
AVTR
Avantor
1/7/2026Lower Price Target$12.09$12.00Hold
MDxHealth SA stock logo
MDXH
MDxHealth
11/13/2025Boost Price Target$4.04$7.00Buy
Waters Corporation stock logo
WAT
Waters
11/5/2025Boost Price Target$372.56$390.00Hold
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/4/2025Boost Price Target$68.93$90.00Buy
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
11/4/2025Boost Price Target$6.50$9.00Hold
Bruker Corporation stock logo
BRKR
Bruker
11/4/2025Boost Price Target$39.95$42.00Hold
Illumina, Inc. stock logo
ILMN
Illumina
10/31/2025Boost Price Target$121.42$115.00Hold
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/23/2025Boost Price Target$564.73$654.00Buy
Danaher Corporation stock logo
DHR
Danaher
10/22/2025Boost Price Target$219.03$260.00Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
10/14/2025Boost Price Target$138.43$162.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Boost Price Target$60.60$72.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
9/12/2025Boost Price Target$8.24$12.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
8/6/2025Boost Price Target$11.54$15.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/1/2025Boost Price Target$48.06$60.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
5/1/2025Lower Price Target$64.88$110.00Buy
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
3/21/2025Lower Price Target$2.31$2.50Neutral
Tempus AI, Inc. stock logo
TEM
Tempus AI
2/5/2025Reiterated Rating$61.85$74.00Buy